Geron Corp has a consensus price target of $5.92, established from looking at the 30 latest analyst ratings. The last 3 analyst ratings were released from Needham, Baird, and TD Cowen on May 2, 2024, April 30, 2024, and April 29, 2024. With an average price target of $6.5 between Needham, Baird, and TD Cowen, there's an implied 69.71% upside for Geron Corp from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|
The latest price target for Geron (NASDAQ: GERN) was reported by Needham on May 2, 2024. The analyst firm set a price target for $5.00 expecting GERN to rise to within 12 months (a possible 30.55% upside). 18 analyst firms have reported ratings in the last year.
The latest analyst rating for Geron (NASDAQ: GERN) was provided by Needham, and Geron reiterated their buy rating.
The last upgrade for Geron Corp happened on September 12, 2023 when Goldman Sachs raised their price target to $4. Goldman Sachs previously had a neutral for Geron Corp.
The last downgrade for Geron Corp happened on April 30, 2024 when Baird changed their price target from N/A to $4.5 for Geron Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Geron, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Geron was filed on May 2, 2024 so you should expect the next rating to be made available sometime around May 2, 2025.
While ratings are subjective and will change, the latest Geron (GERN) rating was a reiterated with a price target of $0.00 to $5.00. The current price Geron (GERN) is trading at is $3.83, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.